HF
CVAC

HRT Financial’s CureVac CVAC Stock Holding History

HRT Financial’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-31,204
Closed -$325K – 2513
2023
Q2 		$325K Buy
+31,204
New +$279K ﹤0.01% 1583
2022
Q3 		– Sell
-108,876
Closed -$1.48M – 2922
2022
Q2 		$1.48M Buy
108,876
+74,640
+218% +$1.23M 0.02% 712
2022
Q1 		$671K Buy
+34,236
New +$684K ﹤0.01% 1422
2021
Q2 		– Sell
-44,007
Closed -$4.02M – 2966
2021
Q1 		$4.02M Buy
44,007
+38,434
+690% +$3.73M 0.04% 333
2020
Q4 		$451K Sell
5,573
-635
-10% -$48.6K 0.01% 1078
2020
Q3 		$288K Buy
+6,208
New +$346K 0.01% 1166

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

HRT Financial's CVAC Position: Q3 2023 in Review

HRT Financial sold out of CureVac (CVAC) in Q3 2023, closing a stake of 31,204 shares — an estimated $325K sold.

HRT Financial first reported a position in CVAC in Q3 2020 and held it in 6 quarters. The position peaked at $4.02M in Q1 2021. 84 funds tracked by Wall St. Rank hold CVAC as of Q3 2023.

  • HRT Financial reported no remaining CureVac position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 31,204 CureVac shares in Q3 2023, an estimated $325K.
  • HRT Financial first reported a position in CureVac in Q3 2020 and held it in 6 quarters.
  • HRT Financial's CureVac position peaked at $4.02M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held CureVac as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.